ArticleOPEN ACCESS

Getting to know JAK

Blood
DOI: 10.1182/blood-2011-09-377291
4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neoplastic clone dominance is key to disease progression. In this issue of Blood, Fleischman et al. suggest that in myeloproliferative neoplasms (MPNs), neoplastic clone dominance is linked to JAK2V617F effects on responsiveness to and production of tumor necrosis factor (TNF)-α.

Cite

CITATION STYLE

APA

Broxmeyer, H. E. (2011, December 8). Getting to know JAK. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-09-377291

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free